Search hospitals
>
North Dakota
>
Fargo
Essentia Health Cancer Center-South University Clinic
Claim this profile
Fargo, North Dakota 58103
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
150 reported clinical trials
2 medical researchers
Summary
Essentia Health Cancer Center-South University Clinic is a medical facility located in Fargo, North Dakota. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Essentia Health Cancer Center-South University Clinic is involved with conducting 150 clinical trials across 299 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.
Area of expertise
Breast Cancer
Essentia Health Cancer Center-South University Clinic has run 36 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Essentia Health Cancer Center-South University Clinic has run 32 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Bret E. Friday
Essentia Health Cancer Center
6 years of reported clinical research
Bret EB Friday
Essentia Health - Deer River Clinic
1 year of reported clinical research
Clinical Trials running at Essentia Health Cancer Center-South University Clinic
Lung Cancer
Bladder Cancer
Breast Cancer
Esophageal cancer
Breast cancer
Pancreatic Cancer
Ovarian Cancer
Colorectal Cancer
Melanoma
Bladder Carcinoma
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Essentia Health Cancer Center-South University Clinic?
Essentia Health Cancer Center-South University Clinic is a medical facility located in Fargo, North Dakota. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Essentia Health Cancer Center-South University Clinic is involved with conducting 150 clinical trials across 299 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.